Nanoengineering may hold the key to developing more effective, safer treatments for a deadly childhood cancer

Neuroblastoma is one of the most common—and lethal—forms of childhood cancer, accounting for 15 percent of pediatric cancer deaths yearly. (Despite the name, neuroblastoma is not a form of brain cancer; it typically consists of tumors found in the abdomen, chest, neck, pelvis, and bones.)